Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IIh-16008649Phase 4Recruiting
Phase 4, open-label, single-arm trial of dasatinib in primary myelofibrosis (PMF), sponsored by The Peoples' Hospital of Jiaozuo City. Primary endpoints: Spleen size and Complete blood count. Started Jun 2014; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IIh-16008649.